What is XSOLIS?
Headquartered in Nashville, Tennessee, XSOLIS operates at the intersection of artificial intelligence and clinical operations. The company specializes in cognitive computing platforms that utilize machine learning and predictive analytics to dismantle traditional silos within the healthcare ecosystem. By providing real-time, data-driven insights, XSOLIS enables hospitals and payers to align on clinical necessity and resource utilization, effectively reducing administrative friction and improving patient outcomes. Its platform serves as a foundational layer for organizations seeking to modernize their revenue cycle management and clinical decision-making processes through advanced computational intelligence.
How much funding has XSOLIS raised?
XSOLIS has raised a total of $77M across 2 funding rounds:
Debt
$2M
Private Equity
$75M
Debt (2020): $2M with participation from PPP
Private Equity (2021): $75M led by Brighton Park Capital
Key Investors in XSOLIS
Brighton Park Capital
Brighton Park Capital is a Greenwich, CT-based investment firm that specializes in software, information services, technology-enabled services, and healthcare. The firm seeks to invest in companies that provide highly innovative solutions and to partner with great management teams and bring purpose-built, value-add capabilities that match the unique requirements of its companies.
PPP
Public-Private Partnership
What's next for XSOLIS?
With the recent influx of capital, XSOLIS is well-positioned to accelerate its product roadmap and expand its footprint in the enterprise healthcare market. The strategic focus will likely center on enhancing the predictive capabilities of its machine learning models and deepening integration with existing electronic health record systems. As the industry shifts toward value-based care, the demand for the company's analytical tools is expected to rise, providing a robust runway for sustained growth. Future initiatives will likely prioritize scaling operations to support larger health networks and refining the cognitive computing engine to address increasingly complex regulatory and clinical challenges.
See full XSOLIS company page
